Free Trial

Sonova (OTCMKTS:SONVY) Hits New 1-Year High - What's Next?

Sonova logo with Medical background

Sonova Holding AG (OTCMKTS:SONVY - Get Free Report)'s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $77.56 and last traded at $77.48, with a volume of 13189 shares trading hands. The stock had previously closed at $71.94.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on SONVY. UBS Group raised Sonova to a "hold" rating in a research note on Tuesday, August 13th. The Goldman Sachs Group raised shares of Sonova to a "strong sell" rating in a research note on Tuesday, October 22nd.

Check Out Our Latest Stock Analysis on Sonova

Sonova Stock Performance

The company has a quick ratio of 1.07, a current ratio of 1.45 and a debt-to-equity ratio of 0.63. The business has a fifty day moving average of $71.34 and a 200 day moving average of $64.66.

Sonova Company Profile

(Get Free Report)

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ The Final Frontier (From Porter & Company) (Ad)

Should you invest $1,000 in Sonova right now?

Before you consider Sonova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.

While Sonova currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar
Top 3 Stocks Under $20 with Strong Buy Ratings and Growth Potential
ISRG Stock Surges: AI and Healthcare Innovation at the Core

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines